454 related articles for article (PubMed ID: 18816868)
21. Amide proton transfer (APT) contrast for imaging of brain tumors.
Zhou J; Lal B; Wilson DA; Laterra J; van Zijl PC
Magn Reson Med; 2003 Dec; 50(6):1120-6. PubMed ID: 14648559
[TBL] [Abstract][Full Text] [Related]
22. Chemical exchange saturation transfer (CEST) imaging with fast variably-accelerated sensitivity encoding (vSENSE).
Zhang Y; Heo HY; Lee DH; Jiang S; Zhao X; Bottomley PA; Zhou J
Magn Reson Med; 2017 Jun; 77(6):2225-2238. PubMed ID: 27364631
[TBL] [Abstract][Full Text] [Related]
23. Amide proton transfer (APT) imaging of brain tumors at 7 T: The role of tissue water T
Khlebnikov V; Polders D; Hendrikse J; Robe PA; Voormolen EH; Luijten PR; Klomp DW; Hoogduin H
Magn Reson Med; 2017 Apr; 77(4):1525-1532. PubMed ID: 27060863
[TBL] [Abstract][Full Text] [Related]
24. Optimization of 7-T chemical exchange saturation transfer parameters for validation of glycosaminoglycan and amide proton transfer of fibroglandular breast tissue.
Dula AN; Dewey BE; Arlinghaus LR; Williams JM; Klomp D; Yankeelov TE; Smith S
Radiology; 2015 Apr; 275(1):255-61. PubMed ID: 25353249
[TBL] [Abstract][Full Text] [Related]
25. Imaging chemical exchange saturation transfer (CEST) effects following tumor-selective acidification using lonidamine.
McVicar N; Li AX; Meakin SO; Bartha R
NMR Biomed; 2015 May; 28(5):566-75. PubMed ID: 25808190
[TBL] [Abstract][Full Text] [Related]
26. Comparing different analysis methods for quantifying the MRI amide proton transfer (APT) effect in hyperacute stroke patients.
Tee YK; Harston GW; Blockley N; Okell TW; Levman J; Sheerin F; Cellerini M; Jezzard P; Kennedy J; Payne SJ; Chappell MA
NMR Biomed; 2014 Sep; 27(9):1019-29. PubMed ID: 24913989
[TBL] [Abstract][Full Text] [Related]
27. Reproducibility of 3 T APT-CEST in Healthy Volunteers and Patients With Brain Glioma.
Wamelink IJHG; Kuijer JPA; Padrela BE; Zhang Y; Barkhof F; Mutsaerts HJMM; Petr J; van de Giessen E; Keil VC
J Magn Reson Imaging; 2023 Jan; 57(1):206-215. PubMed ID: 35633282
[TBL] [Abstract][Full Text] [Related]
28. Comparison of pulsed three-dimensional CEST acquisition schemes at 7 tesla: steady state versus pseudosteady state.
Khlebnikov V; Geades N; Klomp DWJ; Hoogduin H; Gowland P; Mougin O
Magn Reson Med; 2017 Jun; 77(6):2280-2287. PubMed ID: 27455028
[TBL] [Abstract][Full Text] [Related]
29. Relaxation-compensated CEST (chemical exchange saturation transfer) imaging in breast cancer diagnostics at 7T.
Loi L; Zimmermann F; Goerke S; Korzowski A; Meissner JE; Deike-Hofmann K; Stieber A; Bachert P; Ladd ME; Schlemmer HP; Bickelhaupt S; Schott S; Paech D
Eur J Radiol; 2020 Aug; 129():109068. PubMed ID: 32574936
[TBL] [Abstract][Full Text] [Related]
30. Improved Differentiation of Low-Grade and High-Grade Gliomas and Detection of Tumor Proliferation Using APT Contrast Fitted from Z-Spectrum.
Zhang J; Zhu W; Tain R; Zhou XJ; Cai K
Mol Imaging Biol; 2018 Aug; 20(4):623-631. PubMed ID: 29313159
[TBL] [Abstract][Full Text] [Related]
31. Quantification of amide proton transfer effect pre- and post-gadolinium contrast agent administration.
Tee YK; Donahue MJ; Harston GW; Payne SJ; Chappell MA
J Magn Reson Imaging; 2014 Oct; 40(4):832-8. PubMed ID: 24214526
[TBL] [Abstract][Full Text] [Related]
32. Applying amide proton transfer-weighted MRI to distinguish pseudoprogression from true progression in malignant gliomas.
Ma B; Blakeley JO; Hong X; Zhang H; Jiang S; Blair L; Zhang Y; Heo HY; Zhang M; van Zijl PC; Zhou J
J Magn Reson Imaging; 2016 Aug; 44(2):456-62. PubMed ID: 26788865
[TBL] [Abstract][Full Text] [Related]
33. Amide proton transfer-weighted imaging with a short acquisition time based on a self B0 correction using the turbo spin echo-Dixon method: A phantom study.
Tokunaga C; Wada T; Togao O; Kobayashi K; Kato T
Magn Reson Imaging; 2024 Jul; 110():69-77. PubMed ID: 38614223
[TBL] [Abstract][Full Text] [Related]
34. 3D APT and NOE CEST-MRI of healthy volunteers and patients with non-enhancing glioma at 3 T.
Wu Y; Wood TC; Arzanforoosh F; Hernandez-Tamames JA; Barker GJ; Smits M; Warnert EAH
MAGMA; 2022 Feb; 35(1):63-73. PubMed ID: 34994858
[TBL] [Abstract][Full Text] [Related]
35. Observation of true and pseudo NOE signals using CEST-MRI and CEST-MRS sequences with and without lipid suppression.
Lu J; Zhou J; Cai C; Cai S; Chen Z
Magn Reson Med; 2015 Apr; 73(4):1615-22. PubMed ID: 24803172
[TBL] [Abstract][Full Text] [Related]
36. Contrast/Noise ratio on conventional MRI and choline/creatine ratio on proton MRI spectroscopy accurately discriminate low-grade from high-grade cerebral gliomas.
Fayed N; Morales H; Modrego PJ; Pina MA
Acad Radiol; 2006 Jun; 13(6):728-37. PubMed ID: 16679275
[TBL] [Abstract][Full Text] [Related]
37. Role of amide proton transfer imaging in maximizing tumor resection in malignant glioma: a possibility to take the place of
Inoue A; Watanabe H; Kusakabe K; Nishikawa M; Shiraishi Y; Taniwaki M; Takimoto Y; Harada M; Furumochi T; Shigekawa S; Kitazawa R; Kido T; Ohnishi T; Kunieda T
Neurosurg Rev; 2023 Nov; 46(1):294. PubMed ID: 37925381
[TBL] [Abstract][Full Text] [Related]
38. Amide proton transfer imaging of adult diffuse gliomas: correlation with histopathological grades.
Togao O; Yoshiura T; Keupp J; Hiwatashi A; Yamashita K; Kikuchi K; Suzuki Y; Suzuki SO; Iwaki T; Hata N; Mizoguchi M; Yoshimoto K; Sagiyama K; Takahashi M; Honda H
Neuro Oncol; 2014 Mar; 16(3):441-8. PubMed ID: 24305718
[TBL] [Abstract][Full Text] [Related]
39. Amide proton transfer CEST of the cervical spinal cord in multiple sclerosis patients at 3T.
By S; Barry RL; Smith AK; Lyttle BD; Box BA; Bagnato FR; Pawate S; Smith SA
Magn Reson Med; 2018 Feb; 79(2):806-814. PubMed ID: 28474409
[TBL] [Abstract][Full Text] [Related]
40. Quantitative Bayesian model-based analysis of amide proton transfer MRI.
Chappell MA; Donahue MJ; Tee YK; Khrapitchev AA; Sibson NR; Jezzard P; Payne SJ
Magn Reson Med; 2013 Aug; 70(2):556-67. PubMed ID: 23008121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
